Methyl 2-(3,4-dimethoxyphenyl)-2-oxoacetate, 97%, 1g

5,7-Dichloroimidazo[1,2-c]pyrimidine, 95.0%, 5g

6,7-DIFLUOROBENZO[B]THIAZOLO[3,4-D][1,4]OXAZINE-1(4H)-THIONE, 95.0%, 500mg

Ethyl 2-(2-hydroxy-3-nitrophenyl)acetate, 97%, 1g

2-Amino-2-(2,3-dimethoxyphenyl)acetic acid, 98%, 100mg

Fmoc-(S)-3-Amino-4-(4-Trifluoromethyl-phenyl)-butyric acid, 97%, 250mg

ETHYL 4-METHYL-5-OXO-2,5-DIHYDROISOXAZOLE-3-CARBOXYLATE, 95.0%, 1g

2,3,6,7,10,11-Hexamethoxytriphenylene>95.0%(HPLC)1g

Chrysoidin G (CI 11270), pure, 50 g, glass packaging

(S)-1-amino-3-methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one (2R,3R)-2,3-bis(4-methylbenzoyloxy)succinate, 98%, 250mg

tert-Butyl (9-hydroxynonyl)carbamate, 95%, 100mg

Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 5g

DL-Lysine Monohydrochloride>98.0%(T)25g